Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antioxidants and Prevention of Early Atherosclerosis
NCT00000600Phase 2Terminated
- Sponsor
- National Heart, Lung, and Blood Institute
- Start
- Jun 1995
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
A Phase 2 trial of vitamin e, ascorbic acid in atherosclerosis, sponsored by National Heart, Lung, and Blood Institute. Started Jun 1995; status: terminated.
02
Drugs
vitamin eascorbic acid
03
Conditions
atherosclerosis
Beyond the preview
Go deeper on NCT00000600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00000600.